August - 2024

Aug 30

First successful treatment of pediatric high-risk refractory neuroblastoma with PARP inhibition

Scientists and clinicians at St. Jude Children’s Research Hospital identified the genetic vulnerability BARD1 in a patient with pediatric...

Aug 29

Researchers identify malignant cells responsible for relapse in high-risk neuroblastoma

The study marks the first time that researchers identified malignant cells responsible for relapse in neuroblastoma and offers insights...

Aug 27

New research from Children’s Hospital of Philadelphia and St. Jude poised to transform approach to diagnosing and treating acute leukemia in children

Researchers at Children’s Hospital of Philadelphia (CHOP), St. Jude Children’s Research Hospital (St. Jude) and the Children’s Oncology...

Aug 23

Researchers enhance natural killer cells to target pediatric brain cancer

In work published in Bioactive Materials , a research team led by Department of Chemistry and Biochemistry Professor Qing-Xiang "Amy"...

Aug 21

Scientists identify genes linked to relapse in the most common form of childhood leukemia

Researchers identified genetic predictors of relapse in standard risk B-cell acute lymphoblastic leukemia highlighting the role of...

Aug 20

Air pollution linked to worse childhood cancer survival

Exposure to air pollution is associated with worse overall survival (OS) among children with cancer, shows a large US study. Read more:...

Aug 19

Discovery of Key Genetic Driver in Neuroblastoma Paves Way to New Therapeutic Approaches

Led by the Children’s Cancer Institute , a multi-institutional study published in Nature Communications has shown for the first time...

Aug 16

UCLA launches groundbreaking clinical trial for vaccine targeting aggressive pediatric brain cancer

In an effort to combat one of the most lethal forms of pediatric brain cancer, researchers at the UCLA Health Jonsson Comprehensive...

Aug 14

Improved chemokine homing enhances CAR T-cell therapy for osteosarcoma

Scientists at St. Jude Children’s Research Hospital identified chemokines expressed by osteosarcoma that improved CAR T-cell homing, with...

Aug 13

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma...

1

Serum protein panel test can help identify cardiomyopathy risk in childhood cancer survivors

UCalgary researchers help preserve future fertility options for children impacted by cancer

How a Penn State professor developed a cancer-fighting drug for kids

New insights into risk assessment of rare, aggressive tumors in children

CNIO opens up new research pathways against paediatric cancer Ewing sarcoma by discovering mechanisms that make it more aggressive

Larotrectinib Is Promising for Pediatric TRK Fusion-Positive CNS Tumors

Researchers identify gene signature for high-risk form of T-cell acute lymphoblastic leukemia

If My Dying Daughter Could Face Her Mortality, Why Couldn’t the Rest of Us?

FDA Grants Rare Pediatric Designation to Elraglusib for Ewing Sarcoma

Self-reported screening can reduce distressing symptoms for pediatric patients with cancer